Provided by Tiger Trade Technology Pte. Ltd.

DexCom

92.34
+2.122.35%
Post-market: 92.400.0639+0.07%19:56 EDT
Volume:3.48M
Turnover:319.22M
Market Cap:34.85B
PE:36.41
High:92.56
Open:89.61
Low:89.20
Close:90.22
52wk High:92.56
52wk Low:54.11
Shares:377.36M
Float Shares:376.00M
Volume Ratio:0.69
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.54
EPS(LYR):2.09
ROE:38.49%
ROA:10.33%
PB:13.29
PE(LYR):44.19

Loading ...

Mizuho Securities Adjusts DexCom Price Target to $85 From $75, Maintains Outperform Rating

MT Newswires Live
·
Jun 08

DexCom announces results from CONNECT trial of Dexcom G7

TIPRANKS
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

BRIEF-Dexcom Says Use Of Dexcom G7 Leads To Improvement In Glucose Control In People With Type 2 Diabetes Not Using Insulin Versus Routine Care Control Group

Reuters
·
Jun 07

Dexcom Connect Study: the Most Significant Clinical Study Demonstrating Cgm Benefits for People With Type 2 Diabetes Not Using Insulin

THOMSON REUTERS
·
Jun 07

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Reuters
·
Jun 07

Dexcom: Six-Month Extension Phase of Connect Randomized Controlled Trial Is Currently Being Conducted

THOMSON REUTERS
·
Jun 07

Dexcom: in Participants Using Glp-1S, Using Dexcom G7 Resulted in 1.4% Reduction in a1c VS 0.2% in Control Group

THOMSON REUTERS
·
Jun 07

Dexcom: Connect Study Showed Clinically Significant Reduction in a1c When Using Dexcom G7 With Various Combinations Like Metformin, Glp-1S & Sglt2s

THOMSON REUTERS
·
Jun 07

DexCom EVP, Chief Commercial Officer Jon Coleman disposes of common shares worth $726,358.43

Reuters
·
Jun 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)

TIPRANKS
·
Jun 06

DexCom Is Maintained at Buy by Stifel

Dow Jones
·
Jun 05

Stifel Adjusts Price Target on DexCom to $90 From $85, Maintains Buy Rating

MT Newswires Live
·
Jun 05

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), TG Therapeutics (TGTX) and Dexcom (DXCM)

TIPRANKS
·
Jun 04

Dexcom to present clinical findings, product updates at ADA Scientific Sessions

Reuters
·
Jun 04

Dexcom Reaffirms Cgm Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at Ada 2026

THOMSON REUTERS
·
Jun 04

Wells Fargo Releases a Buy Rating on Dexcom (DXCM)

TIPRANKS
·
Jun 02

DexCom Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 02

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

DexCom shareholders elected 12 directors at annual meeting

Reuters
·
May 29